FARICIMAB-SVOA for Product used for unknown indication: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 473 adverse event reports in the FDA FAERS database where FARICIMAB-SVOA was used for Product used for unknown indication.
Most Reported Side Effects for FARICIMAB-SVOA
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 453 | 23.7% | 27 | 28 |
| No adverse event | 259 | 13.6% | 0 | 0 |
| Death | 158 | 8.3% | 153 | 1 |
| Visual impairment | 146 | 7.7% | 1 | 15 |
| Eye inflammation | 136 | 7.1% | 0 | 5 |
| Blindness | 127 | 6.7% | 0 | 8 |
| Endophthalmitis | 125 | 6.6% | 1 | 9 |
| Uveitis | 102 | 5.4% | 0 | 12 |
| Vitritis | 90 | 4.7% | 0 | 13 |
| Drug ineffective | 82 | 4.3% | 0 | 3 |
| Vision blurred | 80 | 4.2% | 0 | 10 |
| Iridocyclitis | 76 | 4.0% | 0 | 9 |
| Vitreous floaters | 65 | 3.4% | 0 | 3 |
| Eye pain | 61 | 3.2% | 0 | 10 |
| Retinal haemorrhage | 51 | 2.7% | 0 | 3 |
Other Indications for FARICIMAB-SVOA
Neovascular age-related macular degeneration (725)
Diabetic retinal oedema (256)
Age-related macular degeneration (117)
Retinal vein occlusion (104)
Macular oedema (77)
Diabetic retinopathy (71)
Macular degeneration (67)
Choroidal neovascularisation (65)
Dry age-related macular degeneration (19)
Retinal neovascularisation (18)
Other Drugs Used for Product used for unknown indication
OXYCODONE (129,391)
ADAPALENE (91,681)
APIXABAN (88,417)
ETANERCEPT (71,866)
SACUBITRIL\VALSARTAN (69,693)
ACETAMINOPHEN (68,427)
AVOBENZONE\OCTISALATE\OCTOCRYLENE (65,206)
ADALIMUMAB (63,549)
EVOLOCUMAB (60,696)
MORPHINE (59,440)